Francisco Ayala de la Peña

Profesor Titular (Oncología Médica)

Universidad de Murcia

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

ORCID

Google Scholar

About

Francisco Ayala de la Peña is a Professor Titular of Medical Oncology at Universidad de Murcia, Spain. His research interests include oncological needs in transgender patients, early breast cancer prognostics, and complications associated with PICC in onco-hematological patients. He has contributed to significant studies on treatment effectiveness in breast cancer and the integration of immune biomarkers and genomic proliferation tumor markers in prognostic models.

Francisco Ayala de la Peña

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Oncological needs in transgender patients

Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes

First-line therapy with palbociclib in patients with advanced HR<SUP>+</SUP>/HER2<SUP>-</SUP> breast cancer: The real-life study PALBOSPAIN

Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?

Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?

A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)

Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer

Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)

Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

A new prognostic model including immune biomarkers, genomic proliferation tumor markers (<i>AURKA</i> and <i>MYBL2</i>) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer

A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge

Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer

Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.

Collaborators (5)

Alexander Kirchmair

Francesca Finotello

Ginés Luengo-Gil

MARIA TERESA MARTINEZ

Eva M. Ciruelos-Gil

How do I reach out?

Meet Kite AI